Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
about
Why bortezomib cannot go with 'green'?Is there a role for complementary therapy in the management of leukemia?Commonly used methods of complementary medicine in the treatment of breast cancerLiver toxicity during temozolomide chemotherapy caused by Chinese herbs.A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid.Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.Bortezomib in kidney transplantation.Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.Intravenous Vitamin C and Cancer: A Systematic Review.Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivoCombination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.Guidelines for supportive care in multiple myeloma 2011.Bortezomib for previously untreated multiple myeloma.Bortezomib for previously untreated multiple myeloma.Chemotherapy-induced peripheral neuropathies in hematological malignancies.Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols.Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.Phytotherapy and Nutritional Supplements on Breast CancerMultiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid.Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter.Bortezomib for the treatment of multiple myeloma.Vitamin C: Overview and Update
P2860
Q24630709-6592BC34-E3A6-403D-ACF8-9C4E3E9741E4Q24642523-55F517C1-1383-4E8D-8AC6-9407959D036FQ27691359-6E7B1471-223E-452C-98D9-9807A954B065Q31154896-FEB4F655-7E64-46B7-892D-A726EA1E82DEQ33586505-87EF06EA-0552-44C1-9842-924AFAD15836Q33748089-39B20F44-A013-4EFB-B483-8945C613A2EDQ34189435-301FDC6F-2750-492D-B4F9-1F6C327831E0Q34729895-0AE4B84D-6E99-4F03-838E-06B35316B0C5Q34788381-88D21342-0400-4717-BB8A-DB95268EC8E8Q35175163-A40A2B30-EC0E-41F6-93C8-0BA20F7CCF10Q35549412-06E6310F-ABF1-49B1-8209-DBD49542520CQ35836872-785E1DDF-E9A8-493C-A53A-9C06D785D3DCQ35836881-E7A1D8F3-BD93-4C45-90B1-D363A981C81EQ36500531-123977AB-15C6-45BE-8EBD-7783C2807AB0Q36589122-E8B62A53-464E-490C-86E3-8D936849715CQ37406743-D6DA7B6B-52AC-43AD-8396-A99B05CDB3BEQ37868637-CEFF8C0C-99C5-4DF6-ADD2-C6524B9AE6F0Q37908155-8AACC37B-CED4-45FE-B2E4-9EDAAEB7031CQ37937699-08C4C4AA-332E-4942-BD5B-5331662A3A19Q38261204-7A500A79-35B3-49F9-B376-FF328C748F59Q38622264-B6F4E05C-21A9-4917-A5B9-3DC231163E9EQ38911003-09D7E770-F501-40A5-A432-8AF55B3A78C7Q39551567-2AA19BAD-5648-47E3-98B9-5B6A75967781Q41463405-F8307C74-9D5A-4120-B36C-BD4BD58019A5Q42009130-402233C1-519B-46D9-8EDE-F78758349A33Q42150701-D205E0C9-B554-4086-BE27-A3FFA171F15FQ47604607-FE5002C1-9CC7-4D2A-82C4-16ACEF13EA19Q57686294-A9995C7A-55C9-4CF6-9489-1402709A8987
P2860
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@ast
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@en
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@nl
type
label
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@ast
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@en
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@nl
prefLabel
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@ast
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@en
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@nl
P2093
P356
P1433
P1476
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
@en
P2093
E Calabrese
K C Anderson
M Baccarani
P2888
P304
P356
10.1038/LEU.2009.83
P577
2009-04-16T00:00:00Z
P5875
P6179
1017594521